Fiduciary Trust Co cut its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.0% during the third quarter, Holdings Channel.com reports. The fund owned 135,843 shares of the company’s stock after selling 1,417 shares during the period. Fiduciary Trust Co’s holdings in Colgate-Palmolive were worth $14,102,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of CL. B. Riley Wealth Advisors Inc. lifted its holdings in Colgate-Palmolive by 0.8% during the first quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock valued at $1,498,000 after purchasing an additional 138 shares in the last quarter. Hancock Whitney Corp lifted its stake in Colgate-Palmolive by 1.3% in the 1st quarter. Hancock Whitney Corp now owns 12,017 shares of the company’s stock valued at $1,082,000 after buying an additional 151 shares in the last quarter. Citizens Financial Group Inc. RI boosted its holdings in Colgate-Palmolive by 12.4% in the 1st quarter. Citizens Financial Group Inc. RI now owns 14,082 shares of the company’s stock worth $1,268,000 after buying an additional 1,549 shares during the last quarter. LRI Investments LLC purchased a new stake in Colgate-Palmolive during the 1st quarter worth approximately $264,000. Finally, Atria Investments Inc raised its holdings in shares of Colgate-Palmolive by 3.2% during the first quarter. Atria Investments Inc now owns 67,625 shares of the company’s stock valued at $6,090,000 after acquiring an additional 2,115 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
CL has been the topic of a number of research analyst reports. Piper Sandler initiated coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target on the stock. UBS Group upped their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price target for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $105.11.
Insider Transactions at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.37% of the company’s stock.
Colgate-Palmolive Trading Up 0.2 %
CL opened at $96.75 on Thursday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market cap of $79.05 billion, a P/E ratio of 27.72, a P/E/G ratio of 3.40 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30. The business has a fifty day simple moving average of $97.61 and a 200-day simple moving average of $98.58.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Are Penny Stocks a Good Fit for Your Portfolio?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the Hang Seng index?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Learn Technical Analysis Skills to Master the Stock Market
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.